Breast Neoplasms: all 12,820 studies

Page 31 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Tango for Neuropathy Among Breast Cancer SurvivorsCompletedNCT05114005Not applicableResults posted
• Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast CancerTerminatedNCT05113966Phase 2Results posted
• Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.CompletedNCT05113927Not applicableResults posted
• Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast CancerActive, not recruitingNCT05113251Phase 3Results posted
• Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast CancerCompletedNCT05112536Phase 2Results posted
• A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)Active, not recruitingNCT05104866Phase 3Results posted
• Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast CancerCompletedNCT05101564Phase 2Results posted
• Intraoperative Evaluation of Axillary LymphaticsCompletedNCT05094102Not applicableResults posted
• PERSONAL - Sleep In Breast CancerCompletedNCT05093426Results posted
• Increasing Breast Cancer Screening in Chinese ImmigrantsCompletedNCT05089292Not applicableResults posted
• EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast CancerCompletedNCT05086705Not applicableResults posted
• COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) ParticipationTerminatedNCT05076266Results posted
• Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast CancerCompletedNCT05073432Not applicableResults posted
• A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTerminatedNCT05070247Phase 1/2Results posted
• A Study of PF-07260437 in Advanced or Metastatic Solid TumorsTerminatedNCT05067972Phase 1Results posted
• A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor CancerCompletedNCT05054374Phase 1/2Results posted
• BRAVE Strategy - Breast Cancer Risk Assessment -achieVing EquityCompletedNCT05051631Not applicableResults posted
• Time Restricted Eating on Cancer RiskCompletedNCT05038137Not applicableResults posted
• Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second OpinionCompletedNCT05036083Not applicableResults posted
• Efficacy and Safety of Tenalisib (RP6530), in Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT05021900Phase 2Results posted
• Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor AloneCompletedNCT05012644Results posted
• Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)CompletedNCT05011279Not applicableResults posted
• Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following MastectomyActive, not recruitingNCT04989504Phase 3Results posted
• Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT04987931Results posted
• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerActive, not recruitingNCT04975308Phase 3Results posted
• Biology Guided Therapy for Breast Cancer for ER PositiveTerminatedNCT04965688Phase 2Results posted
• Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast CancerCompletedNCT04957212Phase 3Results posted
• Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBCCompletedNCT04937660Results posted
• A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior TherapiesTerminatedNCT04927884Phase 1/2Results posted
• Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular DiseaseActive, not recruitingNCT04915755Phase 3Results posted
• HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of GenomicsActive, not recruitingNCT04905082Not applicableResults posted
• A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulationCompletedNCT04903249Not applicableResults posted
• Clinical Outcomes for Offering Genetic Testing in a Tiered ApproachCompletedNCT04902144Not applicableResults posted
• Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or HypnotherapyTerminatedNCT04899492Not applicableResults posted
• Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and FulvestrantTerminatedNCT04899349Phase 2Results posted
• Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer ScreeningTerminatedNCT04877912Results posted
• Patient Experiences With the COVID-19 Vaccination After Breast Cancer TreatmentCompletedNCT04872738Results posted
• Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and ComplianceCompletedNCT04864405Phase 4Results posted
• Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving PaclitaxelCompletedNCT04862585Phase 2/3Results posted
• Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With FulvestrantTerminatedNCT04862143Phase 2Results posted
• Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast CancerTerminatedNCT04849364Phase 2Results posted
• Lighting Intervention for Cancer-related FatigueCompletedNCT04827446Not applicableResults posted
• Pain Control for Breast Cancer Patients Receiving Injection of Radioactive TracerCompletedNCT04822597Phase 3Results posted
• Fluorescence Imaging of Carcinoma During Breast Conserving SurgeryTerminatedNCT04815083Phase 3Results posted
• Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.TerminatedNCT04796324Phase 2Results posted
• Anti-anxiety Biotics for Breast Cancer SurvivorsTerminatedNCT04784182Not applicableResults posted
• Screening Contrast-Enhanced Mammography as an Alternative to MRICompletedNCT04764292Phase 4Results posted
• KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural PracticeCompletedNCT04763824Not applicableResults posted
• A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast CancerTerminatedNCT04752332Phase 3Results posted
• Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast CancerCompletedNCT04750473Phase 1Results posted
• TOPS for African American Breast Cancer SurvivorsCompletedNCT04741802Not applicableResults posted
• A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)TerminatedNCT04740918Phase 3Results posted
• A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast CancerActive, not recruitingNCT04739761Phase 3Results posted
• Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.Active, not recruitingNCT04739696Not applicableResults posted
• Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)TerminatedNCT04738292Phase 2Results posted
• Pilot Study of an NTproBNP Guided Strategy of CardioprotectionCompletedNCT04737265Phase 1/2Results posted
• Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine MonotherapyCompletedNCT04736576Not applicableResults posted
• Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus LetrozoleCompletedNCT04735367Results posted
• A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001)Active, not recruitingNCT04721977Phase 2Results posted
• Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast CancerCompletedNCT04721886Early Phase 1Results posted
• Oral SM-88 in Patients With Metastatic HR+/HER2- Breast CancerTerminatedNCT04720664Phase 2Results posted
• Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical ActivityCompletedNCT04717050Not applicableResults posted
• A Study of Abemaciclib in Indian Women With Advanced Breast CancerCompletedNCT04707196Phase 4Results posted
• A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast CancerCompletedNCT04699630Phase 2Results posted
• Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted TherapyActive, not recruitingNCT04692103Phase 2Results posted
• A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast CancerTerminatedNCT04690855Phase 2Results posted
• The E-consult Application for Patients With Breast Cancer: Interest in Empathy and Empowerment of Patients.CompletedNCT04688762Results posted
• A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast CancersCompletedNCT04688086Results posted
• A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.CompletedNCT04671615Results posted
• Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE TrialCompletedNCT04667481Not applicableResults posted
• Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based CohortsTerminatedNCT04657679Phase 4Results posted
• Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase InhibitorActive, not recruitingNCT04650581Phase 3Results posted
• A Study of LY3484356 in Women With Breast Cancer Before Having SurgeryCompletedNCT04647487Phase 1Results posted
• Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung CancerTerminatedNCT04639245Phase 1/2Results posted
• A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast CancerCompletedNCT04588298Phase 2Results posted
• Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryTerminatedNCT04588246Phase 3Results posted
• Niraparib + Dostarlimab In BRCA Mutated Breast CancerActive, not recruitingNCT04584255Phase 2Results posted
• Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive DesignCompletedNCT04583891Not applicableResults posted
• Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsActive, not recruitingNCT04579380Phase 2Results posted
• Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant TherapyTerminatedNCT04578106Phase 2Results posted
• A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid TumorsTerminatedNCT04577963Phase 1/2Results posted
• A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)Active, not recruitingNCT04576455Phase 2Results posted
• Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer RiskTerminatedNCT04570956Phase 2Results posted
• Assessing Tissue Dielectric Constant (TDC) to Differentiate Breast Cancer Breast Cancer From Healthy BreastsCompletedNCT04561297Not applicableResults posted
• Mindful After Cancer: A Mindfulness-based Therapy Intervention for Sexual Health After CancerCompletedNCT04559854Not applicableResults posted
• Sulindac and Breast Density in Women at Risk of Developing Breast CancerCompletedNCT04542135Phase 2Results posted
• A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast CancerCompletedNCT04539938Phase 2Results posted
• Decellularized, Whole Donor Nipple-Areola Complex Reconstruction GraftsTerminatedNCT04534010Not applicableResults posted
• Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast CancerTerminatedNCT04504331Phase 1Results posted
• Adaptive Nutrition and Exercise Weight Loss (A-NEW) StudyCompletedNCT04499950Phase 2Results posted
• Palbociclib and Binimetinib in Advanced Triple Negative Breast CancerCompletedNCT04494958Phase 1/2Results posted
• Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast CancerActive, not recruitingNCT04494425Phase 3Results posted
• Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase InhibitorsTerminatedNCT04493333Phase 2Results posted
• Implementing BREASTChoice Into PracticeCompletedNCT04491591Not applicableResults posted
• Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast CancerTerminatedNCT04489940Phase 2Results posted
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast CancerTerminatedNCT04478266Phase 3Results posted
• A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast CancerTerminatedNCT04461600Phase 2Results posted
• Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.CompletedNCT04460911Results posted
• RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.CompletedNCT04460898Results posted
• Pain Monitoring After Breast Biopsy: Benefit of E-healthCompletedNCT04456920Not applicableResults posted

← Breast Neoplasms overview